Edition:
United Kingdom

Illumina Inc (ILMN.OQ)

ILMN.OQ on NASDAQ Stock Exchange Global Select Market

312.75USD
18 Jan 2019
Change (% chg)

-- (--)
Prev Close
$312.75
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
402,474
52-wk High
$372.46
52-wk Low
$207.94

Chart for

About

Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc. (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of... (more)

Overall

Beta: 0.74
Market Cap(Mil.): $29,871.53
Shares Outstanding(Mil.): 146.30
Dividend: --
Yield (%): --

Financials

  ILMN.OQ Industry Sector
P/E (TTM): 40.23 195.02 33.71
EPS (TTM): 5.07 -- --
ROI: 18.76 9.63 14.48
ROE: 31.34 15.55 15.99

Illumina to buy rival Pacific Biosciences in $1.2 billion deal

Gene sequencing company Illumina Inc said http://pdf.reuters.com/htmlnews/htmlnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20181101:nBw18KCRQa on Thursday it plans to buy smaller rival Pacific Biosciences of California Inc in an all-cash deal valued at $1.2 billion, expanding its capabilities as the market grows.

01 Nov 2018

UPDATE 1-Illumina to buy rival Pacific Biosciences in $1.2 bln deal

Nov 1 Gene sequencing company Illumina Inc said http://pdf.reuters.com/htmlnews/htmlnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20181101:nBw18KCRQa on Thursday it plans to buy smaller rival Pacific Biosciences of California Inc in an all-cash deal valued at $1.2 billion, expanding its capabilities as the market grows.

01 Nov 2018

Gene sequencing company Illumina to buy Pacific Biosciences in $1.2 billion deal

Gene sequencing company Illumina Inc said http://pdf.reuters.com/htmlnews/htmlnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20181101:nBw18KCRQa on Thursday it plans to buy Pacific Biosciences of California Inc in an all-cash deal valued at $1.2 billion.

01 Nov 2018

Gene sequencing company Illumina to buy Pacific Biosciences in $1.2 bln deal

Nov 1 Gene sequencing company Illumina Inc said http://pdf.reuters.com/htmlnews/htmlnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20181101:nBw18KCRQa on Thursday it plans to buy Pacific Biosciences of California Inc in an all-cash deal valued at $1.2 billion.

01 Nov 2018

Earnings vs. Estimates